Featured links
Research publications
Explore our online library of scientific publications
Research programs
Learn more about our expertise and R&D programs
Our facilities
Discover our unique research facilities and labs
Collaboration
Work with our experts to accelerate your projects
Stories
Read about some of our research projects
Services and information
Designing, developing and producing innovative biologics in Canada
Biologics are vaccines and therapeutics derived from living organisms or from their cells and are produced using advanced biotechnology processes. With our multidisciplinary expertise, we design, develop and test novel biologics to treat Canadians and to prevent them from getting sick in the first place.
Innovative biologics
We develop biologics for complex health challenges, such as emerging infections, cancer and neurological diseases
Biomanufacturing
We use our expertise to improve the production process for complex biologics
Cell and gene therapies
We collaborate to advance personalized and off-the-shelf biologics, such as cell and gene therapies
Multidisciplinary expertise in biologics development
With one of the largest research and development teams dedicated to biologics development in Canada, we collaborate with industry, hospitals, health networks, academia and government to advance novel biologics. Our technical expertise, advisory services and leading-edge facilities span the biologics development process—from discovery to clinical material production.
Design
Generate high-potential candidates with our proprietary cell lines, multifunctional antibodies, vectors and adjuvants
Preclinical R&D
Evaluate biologic candidates with our small-scale manufacturing capabilities and in vivo and in vitro testing expertise
Bioprocess R&D
Improve bioprocesses with our expertise and R&D labs for in-process scale-up, analytics, modelling and intensification
Production of clinical trial material
Optimize bioprocesses in compliance with good manufacturing practices (GMP) and produce biologics at clinical scale in our specialized facility
Image gallery
 |
 |
 |
 |
 |
 |
 |
Contact us
Sue Twine
Director General
Telephone: 613-668-5814
Email: Susan.Twine@nrc-cnrc.gc.ca
Paul Payette
Director
Business Development
Telephone: 613-204-8374
Email: Paul.Payette@nrc-cnrc.gc.ca
Media Relations
National Research Council of Canada
Email: NRC.MediaRelations-RelationsMedias.CNRC@nrc-cnrc.gc.ca
Directory of science professionals
View our researcher profiles to learn about their projects, passions and expertise.
View our human health therapeutics scientific experts.
Advisory Board members
The Research Centre Advisory Boards provide perspectives and advice on overall strategic direction and priorities.
Features
Canadian innovations in CAR T-cell cancer therapy
We’re collaborating on the development of cutting-edge, made-in-Canada CAR T-cell therapies, offering an exciting new way to treat cancer.
Production of clinical trial material
Bridging R&D and commercial production, our newest facility helps Canadian-made biopharmaceuticals advance to clinical trials in Canada.
Persistence in the fight against antimicrobial resistance
We play a leading role in collaborative research tackling the antimicrobial resistance crisis, sometimes called the "silent pandemic."